Proteolytic Activity of Indigenous Lactic Acid Bacteria and Angiotensin-I-Converting Enzyme (ACE) Inhibitory Activity in Fermented Soy Milk

2020 ◽  
Vol 19 (6) ◽  
pp. 295-302
Author(s):  
Yuliana Tandi Ruba ◽  
Lilis Nuraida ◽  
Dyah Iswantini ◽  
Endang Prangdimur
2005 ◽  
Vol 10 (3) ◽  
pp. 239-243 ◽  
Author(s):  
Rohan Karawita ◽  
Pyo-Jam park ◽  
Nalin Siriwardhana ◽  
Byong-Tae Jeon ◽  
Sang-Ho Moon ◽  
...  

Biomolecules ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. 101 ◽  
Author(s):  
Guowei Shu ◽  
Jie Huang ◽  
Chunju Bao ◽  
Jiangpeng Meng ◽  
He Chen ◽  
...  

Angiotensin I-converting enzyme (ACE) peptides are bioactive peptides that have important value in terms of research and application in the prevention and treatment of hypertension. While widespread literature is concentrated on casein or whey protein for production of ACE-inhibitory peptides, relatively little information is available on selecting the proper proteases to hydrolyze the protein. In this study, skimmed cow and goat milk were hydrolyzed by four commercial proteases, including alkaline protease, trypsin, bromelain, and papain. Angiotensin I-converting enzyme-inhibitory peptides and degree of hydrolysis (DH) of hydrolysates were measured. Moreover, we compared the difference in ACE-inhibitory activity between cow and goat milk. The results indicated that the DH increased with the increase in hydrolysis time. The alkaline protease-treated hydrolysates exhibited the highest DH value and ACE-inhibitory activity. Additionally, the ACE-inhibitory activity of hydrolysates from goat milk was higher than that of cow milk-derived hydrolysates. Therefore, goat milk is a good source to obtain bioactive peptides with ACE-inhibitory activity, as compared with cow milk. A proper enzyme to produce ACE-inhibitory peptides is important for the development of functional milk products and will provide the theoretical basis for industrial production.


2007 ◽  
Vol 54 (4) ◽  
pp. 160-166 ◽  
Author(s):  
Jin Shan ◽  
Yuka Ogawa ◽  
Takao Watanabe ◽  
Riichiro Morimoto ◽  
Shoko Oota ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (65) ◽  
pp. 37451-37461 ◽  
Author(s):  
Limo Zhang ◽  
Yunsong Jiang ◽  
Zhongtian Yin ◽  
Jinyuan Sun ◽  
Hehe Li ◽  
...  

Two tripeptides with ACE inhibitory activity were isolated from Jiupei (the raw material of Baijiu) distillation.


2002 ◽  
Vol 50 (24) ◽  
pp. 6981-6988 ◽  
Author(s):  
P. K. Janitha P. D. Wanasundara ◽  
Andrew R. S. Ross ◽  
Ryszard Amarowicz ◽  
Steve J. Ambrose ◽  
Ronald B. Pegg ◽  
...  

2003 ◽  
Vol 69 (9) ◽  
pp. 5297-5305 ◽  
Author(s):  
F. Minervini ◽  
F. Algaron ◽  
C. G. Rizzello ◽  
P. F. Fox ◽  
V. Monnet ◽  
...  

ABSTRACT Sodium caseinates prepared from bovine, sheep, goat, pig, buffalo or human milk were hydrolyzed by a partially purified proteinase of Lactobacillus helveticus PR4. Peptides in each hydrolysate were fractionated by reversed-phase fast-protein liquid chromatography. The fractions which showed the highest angiotensin I-converting-enzyme (ACE)-inhibitory or antibacterial activity were sequenced by mass spectrum and Edman degradation analyses. Various ACE-inhibitory peptides were found in the hydrolysates: the bovine αS1-casein (αS1-CN) 24-47 fragment (f24-47), f169-193, and β-CN f58-76; ovine αS1-CN f1-6 and αS2-CN f182-185 and f186-188; caprine β-CN f58-65 and αS2-CN f182-187; buffalo β-CN f58-66; and a mixture of three tripeptides originating from human β-CN. A mixture of peptides with a C-terminal sequence, Pro-Gly-Pro, was found in the most active fraction of the pig sodium caseinate hydrolysate. The highest ACE-inhibitory activity of some peptides corresponded to the concentration of the ACE inhibitor (S)-N-(1-[ethoxycarbonyl]-3-phenylpropyl)-ala-pro maleate (enalapril) of 49.253 μg/ml (100 μmol/liter). Several of the above sequences had features in common with other ACE-inhibitory peptides reported in the literature. The 50% inhibitory concentration (IC50) of some of the crude peptide fractions was very low (16 to 100 μg/ml). Some identified peptides were chemically synthesized, and the ACE-inhibitory activity and IC50s were confirmed. An antibacterial peptide corresponding to β-CN f184-210 was identified in human sodium caseinate hydrolysate. It showed a very large spectrum of inhibition against gram-positive and -negative bacteria, including species of potential clinical interest, such as Enterococcus faecium, Bacillus megaterium, Escherichia coli, Listeria innocua, Salmonella spp., Yersinia enterocolitica, and Staphylococcus aureus. The MIC for E. coli F19 was ca. 50 μg/ml. Once generated, the bioactive peptides were resistant to further degradation by proteinase of L. helveticus PR4 or by trypsin and chymotrypsin.


Sign in / Sign up

Export Citation Format

Share Document